Arvinas (ARVN) Common Equity (2017 - 2026)

Arvinas (ARVN) recorded quarterly Common Equity of $386.8 million in Q1 2026, down 10.86% quarter-over-quarter from $433.9 million in Q4 2025, and down 41.4% on a YoY basis from $660.1 million in Q1 2025.

Arvinas (ARVN) Common Equity (2017 - 2026) Analysis & Trends

Arvinas' Common Equity history runs 10 years deep, the most recent figure standing at $386.8 million for Q1 2026.

  • In Q1 2026, Common Equity fell 41.4% year-over-year to $386.8 million; the TTM figure through Mar 2026 stood at $386.8 million (down 41.4% YoY), while the FY2025 annual figure was $433.9 million, down 22.75% from the prior year.
  • Common Equity was $386.8 million for Q1 2026 at Arvinas, down from $433.9 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $723.3 million in Q1 2022 to a low of $386.8 million in Q1 2026.
  • Historically, Common Equity has averaged $569.7 million across 5 years, with a median of $586.0 million in 2024.
  • The sharpest annual moves came in 2024 and 2026: Common Equity climbed 29.47% in 2024, then plunged 41.4% in 2026.
  • A 5-year view of Common Equity shows it stood at $564.9 million in 2022, then rose by 16.83% to $660.0 million in 2023, then retreated by 14.89% to $561.7 million in 2024, then fell by 22.75% to $433.9 million in 2025, then dropped by 10.86% to $386.8 million in 2026.
  • The last three Common Equity figures came in at $386.8 million (Q1 2026), $433.9 million (Q4 2025), and $564.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 35.63 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -1.42 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 13.21 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 11.87 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arvinas 492.16 Mn -122.74 Mn - 386.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 386.80 Mn
Dec 31, 2025 433.90 Mn
Sep 30, 2025 564.40 Mn
Jun 30, 2025 609.30 Mn
Mar 31, 2025 660.10 Mn
Dec 31, 2024 561.70 Mn
Sep 30, 2024 586.00 Mn
Jun 30, 2024 600.20 Mn
Mar 31, 2024 609.70 Mn
Dec 31, 2023 660.00 Mn
Sep 30, 2023 457.20 Mn
Jun 30, 2023 463.60 Mn
Mar 31, 2023 511.00 Mn
Dec 31, 2022 564.90 Mn
Sep 30, 2022 621.50 Mn
Jun 30, 2022 670.60 Mn
Mar 31, 2022 723.30 Mn
Dec 31, 2021 781.70 Mn
Sep 30, 2021 817.70 Mn
Jun 30, 2021 582.90 Mn